Anti-Mre11 antibody [12D7] - BSA and Azide free
5
(10 Reviews)
|
(107 Publications)
Mouse Monoclonal MRE11 antibody. Carrier free. Suitable for IP, Flow Cyt, WB, ICC/IF and reacts with Human samples. Cited in 107 publications. Immunogen corresponding to Synthetic Peptide within Human MRE11 aa 150 to C-terminus.
View Alternative Names
HNGS1, MRE11A, MRE11, Double-strand break repair protein MRE11, Meiotic recombination 11 homolog 1, Meiotic recombination 11 homolog A, MRE11 homolog 1, MRE11 homolog A
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Mre11 antibody [12D7] - BSA and Azide free (AB214)
Immunocytochemical analysis of, 4% paraformaldehyde-fixed at RT for 15 min, HeLa (Human epithelial cell line from cervix adenocarcinoma) cells labeling Mre-11 (green) with ab214 at 1/200 dilution. Blue : Hoechst 33342 staining. Scale bar= 10 μm.
- Flow Cyt
Unknown
Flow Cytometry - Anti-Mre11 antibody [12D7] - BSA and Azide free (AB214)
Overlay histogram showing HeLa cells stained with ab214 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab214, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was a goat anti-mouse DyLight® 488 (IgG, H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HeLa cells fixed with 4% paraformaldehyde (10 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.
This image was generated using the ascites version of the product.
- WB
Supplier Data
Western blot - Anti-Mre11 antibody [12D7] - BSA and Azide free (AB214)
Samples were separated by 7.5% SDS-PAGE.
All lanes:
Western blot - Anti-Mre11 antibody [12D7] - BSA and Azide free (ab214) at 1/1000 dilution
Lane 1:
293T whole cell extracts at 30 µg
Lane 2:
A431 whole cell extracts at 30 µg
Secondary
All lanes:
HRP-conjugated anti-mouse IgG antibody
false
- WB
Supplier Data
Western blot - Anti-Mre11 antibody [12D7] - BSA and Azide free (AB214)
Samples were separated by 7.5% SDS-PAGE.
All lanes:
Western blot - Anti-Mre11 antibody [12D7] - BSA and Azide free (ab214) at 1/1000 dilution
Lane 1:
U87-MG whole cell extracts at 30 µg
Lane 2:
SK-N-SH whole cell extracts at 30 µg
Lane 3:
IMR32 whole cell extracts at 30 µg
Lane 4:
SK-N-AS whole cell extracts at 30 µg
Secondary
All lanes:
HRP-conjugated anti-mouse IgG antibody
false
- WB
Supplier Data
Western blot - Anti-Mre11 antibody [12D7] - BSA and Azide free (AB214)
This image was generated using the ascites version of the product.
7.5% SDS-PAGE
All lanes:
Western blot - Anti-Mre11 antibody [12D7] - BSA and Azide free (ab214) at 1/1000 dilution
Lane 1:
HEK-293T (Human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate at 30 µg
Lane 2:
Human Mre-11-transfected HEK-293T whole cell lysate at 30 µg
Secondary
All lanes:
anti-mouse IgG HRP-conjugated antibody
Predicted band size: 80 kDa
false
- ICC/IF
CiteAb
Immunocytochemistry/ Immunofluorescence - Anti-Mre11 antibody [12D7] - BSA and Azide free (AB214)
Immunocytochemistry-immunofluorescence using Anti-Mre11 antibody [12D7] - BSA and Azide free, ab214. Publication image from Bohr, V. A. et al., 2016, Nat Commun, 27922005. Legend direct from paper.
WRN inhibits the recruitment of MRE11 and CtIP to DSBs.(a) Confocal microphotographs showing cell cycle independent recruitment of WRN to laser-induced DSBs in U2OS cells. Graph represents data from >200 cells. gH2AX; gamma H2AX. (b) WRN depletion increases MRE11 recruitment to DSBs in G1 cells. siRNA transfected U2OS cells were microirradiated and immunostained for cyclin A2, WRN and MRE11. Graph indicates MRE11 recruitment to laser-induced DSBs in control and WRN siRNA transfected S/G2 and G1 cells. n; number of cells. (c) WRN knockdown promotes CtIP recruitment to laser-induced DSBs. Control (siC) and WRN knockdown U2OS cells were microirradiated to generate DSBs and immunostained with WRN, CtIP and cyclin A2 antibodies. Cyclin A2 positive cells indicate cells in S/G2 phase. (d) Quantitation of CtIP and WRN signals at DSBs as seen in panel E. n=26 cells per set (e) Recruitment kinetics of mCherry-WRN and YFP-MRE11 to laser-induced DSBs in U2OS cells. n=14 cells (f) Real-time recruitment of YFP-MRE11 to laser-induced DSBs in WS cells, AG11395, expressing no WRN (vector control) and mCherry-WRN. n=28 cells (g) Recruitment of GFP-CtIP to laser-induced DSBs in AG11395 WS cells transfected with or without mCherry WRN. n=22 cells. Yellow arrow heads in panel A, B and C indicate laser-induced DSB tracks. a.u., arbitrary unit.
- Other
CiteAb
Other - Anti-Mre11 antibody [12D7] - BSA and Azide free (AB214)
Proximity Ligation Assay using Anti-Mre11 antibody [12D7] - BSA and Azide free, ab214. Publication image from Nieminuszczy, J. et al., 2019, Mol Cell, 31255466. Legend direct from paper.
EXD2 Is Recruited to Stressed Replication Forks(A) Western blot of iPOND samples. Thymidine chase analysis illustrates that EXD2 specifically associates with the replisome. PCNA acts as a control.(B) Schematic of the proximity ligation assay (PLA) employed to detect colocalization of target proteins with nascent DNA.(C) Percentage of cells with MRE11/biotin PLA foci (mean ± SEM, n = 3 independent experiments, t test). Right : representative images of PLA foci (red), DAPI acts as a nuclear counterstain. Scale bar, 10 µm.(D) Percentage of cells with GFP/biotin PLA foci (mean ± SEM, n = 3 independent experiments, t test) in U2OS control cells and U2OS cells expressing GFP-EXD2. Right : representative images of PLA foci (red), DAPI acts as a nuclear counterstain. Scale bar, 10 µm.(E) Laser microirradiation induces rapid redistribution of GFP-EXD2 to damaged chromatin; representative images showing GFP-EXD2 accumulation at laser-generated DNA lesions. GFP-CtIP was used as a positive control. Scale bar, 10 µm.(F) Quantification of GFP-EXD2 (left panel) and GFP-CtIP (right panel) recruitment kinetics (intensity versus time) to laser-generated DNA lesions (mean ± SE, n ≥ 10 cells from 2 independent experiments).
Reactivity data
Product details
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This protein acts in the repair of DSBs by initiating homologous recombination and non-homologous end joining pathways. Together with the RAD50 and NBS1 proteins Mre11 forms the MRN complex which processes DNA ends and signals to other repair mechanisms. Additionally Mre11's exonuclease and endonuclease activities are important for the resection of DNA at break sites facilitating subsequent repair synthesis.
Pathways
Mre11 is instrumental in the DNA damage response and maintenance of genomic integrity. It operates within the ATM (ataxia-telangiectasia mutated) signaling pathway which activates upon DNA damage and regulates cell cycle checkpoints. Mre11 interacts with the ATM protein modifying the cellular response to DNA damage. The complex also collaborates closely with BRCA1 an important regulator of the repair process and associated with preventing breast cancer development.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (107)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:7214 PubMed40764480
2025
Applications
Unspecified application
Species
Unspecified reactive species
iScience 28:112624 PubMed40546945
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nucleic acids research 53: PubMed40479710
2025
Applications
Unspecified application
Species
Unspecified reactive species
Oncotarget 16:362-378 PubMed40387816
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:4491 PubMed40368919
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular biology of the cell 36:ar11 PubMed39705374
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nucleic acids research 52:8320-8331 PubMed38917325
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 27:108925 PubMed38323009
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:7882 PubMed38036565
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed37446144
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com